ask="N/A"
ask_size="N/A"
average_daily_volume="31044"
bid="3.12"
bid_size="100"
book_value="3.34"
change="-0.02"
change_from_200_day_moving_average="1.17"
change_from_50_day_moving_average="1.88"
change_from_52_week_high="-2.03"
change_From_52_week_low="4.24"
change_in_percent="-0.26%"
close="7.76"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.60"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.84"
ex_dividend_date="N/A"
float_shares="686000"
high="8.50"
high_52_weeks="9.79"
last_trade_date="1/23/2017"
last_trade_price="7.76"
last_trade_size="828"
last_trade_time="4:00pm"
low="7.60"
low_52_weeks="3.52"
market_capitalization="165.13M"
moving_average_200_day="6.59"
moving_average_50_day="5.88"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="16.20"
open="7.83"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+17.68%"
percent_change_from_50_day_moving_average="+31.89%"
percent_change_from_52_week_high="-20.71%"
percent_change_from_52_week_low="+120.45%"
previous_close="7.78"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.33"
price_per_sales="31.84"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="4.80"
stock_exchange="NMS"
symbol="NBRV"
volume="50545"
weeks_range_52="3.52 - 9.79"
